1. Home
  2. SAMG vs CGEN Comparison

SAMG vs CGEN Comparison

Compare SAMG & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$14.40

Market Cap

125.5M

Sector

Finance

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.27

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
CGEN
Founded
2002
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.5M
148.7M
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
SAMG
CGEN
Price
$14.40
$2.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
17.2K
324.9K
Earning Date
06-19-2026
01-01-0001
Dividend Yield
5.94%
N/A
EPS Growth
N/A
N/A
EPS
0.56
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.62
$58.57
P/E Ratio
$25.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.23
$1.13
52 Week High
$16.97
$2.38

Technical Indicators

Market Signals
Indicator
SAMG
CGEN
Relative Strength Index (RSI) 33.07 64.67
Support Level $13.41 $1.45
Resistance Level $15.50 $2.36
Average True Range (ATR) 0.46 0.15
MACD -0.13 0.03
Stochastic Oscillator 15.16 88.10

Price Performance

Historical Comparison
SAMG
CGEN

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: